1. Home
  2. UG vs PTHL Comparison

UG vs PTHL Comparison

Compare UG & PTHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UG
  • PTHL
  • Stock Information
  • Founded
  • UG 1942
  • PTHL 1998
  • Country
  • UG United States
  • PTHL China
  • Employees
  • UG N/A
  • PTHL N/A
  • Industry
  • UG Package Goods/Cosmetics
  • PTHL
  • Sector
  • UG Consumer Discretionary
  • PTHL
  • Exchange
  • UG Nasdaq
  • PTHL Nasdaq
  • Market Cap
  • UG 50.1M
  • PTHL 43.1M
  • IPO Year
  • UG N/A
  • PTHL 2024
  • Fundamental
  • Price
  • UG $10.50
  • PTHL $3.00
  • Analyst Decision
  • UG
  • PTHL
  • Analyst Count
  • UG 0
  • PTHL 0
  • Target Price
  • UG N/A
  • PTHL N/A
  • AVG Volume (30 Days)
  • UG 8.5K
  • PTHL 34.5K
  • Earning Date
  • UG 03-21-2025
  • PTHL 02-11-2025
  • Dividend Yield
  • UG 6.63%
  • PTHL N/A
  • EPS Growth
  • UG 38.11
  • PTHL N/A
  • EPS
  • UG 0.76
  • PTHL N/A
  • Revenue
  • UG $12,312,275.00
  • PTHL $572,291.00
  • Revenue This Year
  • UG N/A
  • PTHL N/A
  • Revenue Next Year
  • UG N/A
  • PTHL N/A
  • P/E Ratio
  • UG $14.25
  • PTHL N/A
  • Revenue Growth
  • UG 11.51
  • PTHL 2.32
  • 52 Week Low
  • UG $7.02
  • PTHL $1.96
  • 52 Week High
  • UG $16.25
  • PTHL $6.45
  • Technical
  • Relative Strength Index (RSI)
  • UG 44.74
  • PTHL N/A
  • Support Level
  • UG $10.31
  • PTHL N/A
  • Resistance Level
  • UG $11.08
  • PTHL N/A
  • Average True Range (ATR)
  • UG 0.38
  • PTHL 0.00
  • MACD
  • UG -0.07
  • PTHL 0.00
  • Stochastic Oscillator
  • UG 23.85
  • PTHL 0.00

About UG United-Guardian Inc.

United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.

About PTHL Pheton Holdings Ltd Class A Ordinary Shares

Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.

Share on Social Networks: